Swiss businesses warn of economic consequences from capping population at exactly 10 million.

On June 14, the Swiss will make a crucial decision regarding a right-wing proposal to limit their population to exactly 10 million. Proponents argue that unchecked population expansion is putting immense pressure on the country's housing and infrastructure.

A crucial referendum is scheduled for June 14, where voters will decide on capping Switzerland's population at exactly 10 million individuals. Many entrepreneurs are deeply concerned about potential economic repercussions if this cap is implemented.

Proponents of a 10 million population cap, led by the SVP, claim that unchecked growth strains local infrastructure, pushes road capacity to its limits, and fuels rising housing costs and increased crime rates.

Switzerland's business sector is concerned that capping the population at 10 million could severely impact their ability to attract top talent from abroad.

Martin von Moos, CEO of Belvoir in Ruschlikon and Sedartis in Thalwil, expresses deep concern about the future economic prospects for Switzerland if its population is capped at exactly 10 million.

The hotel's operations would be severely impacted if it were to lose its international workforce, which comprises almost half of its total staff of 115 employees.

Recent research has yielded a closely divided outcome, with the latest survey indicating that nearly half support the proposal while slightly more are opposed.

By the end of 2025, the country's population had reached a milestone of exactly 9.1 million, up significantly from its pre-2002 level of 7.3 million residents.

Approximately one quarter of residents are foreign nationals currently.

With a relatively small landmass, Switzerland has seen an unprecedented surge in population over recent years, according to SVP lawmaker Yvan Puhad's candid assessment.

Right-wing parties are exploiting public concerns about immigration, housing, and public services, echoing sentiments that fueled Britain's Brexit decision in 2016 and the growing support for parties like France's National Rally and Germany's AfD.

Economists warn that imposing a population cap may severely impact the stability of some of Europe's strongest economic systems.

Zurich-based Molecular Partners, a biotech firm with around 120 employees, has a significant proportion of its workforce comprised of individuals from outside Switzerland, citing difficulties in recruitment.

Daniel Steiner, senior vice president for targeted radio therapeutics, believes that limiting hiring to Swiss talent or collaborating solely with Swiss companies would be a major obstacle.

The population cap could lead to relocation efforts.

Economiesuisse's chief economist Rudolf Minsch described the population cap as a misguided solution to intricate issues, imposing an arbitrary constraint.

Minsch warns that this proposal creates an unrealistic expectation, neglecting underlying issues like affordable housing and congestion.

Switzerland's demographic profile is characterized by an aging population trend.

By mid-century projections indicate a significant shift in Switzerland's demographic landscape, with the working-age population expected to shrink by four percentage points to 56% between 20 and 64 years old. Conversely, the elderly segment is forecasted to surge to nearly one-quarter of the total population, up from its current level of 21%.

Critics claim that many recent arrivals to Switzerland have been entrepreneurial pioneers who drove economic growth, pointing to household names like Nestle, Swatch, and ABB, which were founded in part by foreign investors.

A 2023 study conducted by Avenir Suisse found that nearly four out of ten Swiss startup founders are foreign nationals.

Molecular Partners Molecular Partners, a biotech firm with around 120 employees, has a significant proportion of its workforce comprised of individuals from outside Switzerland, citing difficulties in recruitment.

Voting is an integral part of Switzerland's democratic system, with citizens casting their ballots approximately four times annually to address diverse national and local concerns.

A proposed limit on Switzerland's population growth would kick in when the current estimate of 9.5 million residents is reached by 2031, prompting authorities to intervene and prevent a projected milestone of 10 million inhabitants by 2042 from being surpassed.

Requiring a population of 10 million, Bern must renegotiate its international agreements promoting population expansion.

The deal with the EU enables Switzerland's participation in the European single market, contingent upon the free movement of individuals as stipulated by the intricate network of agreements between Bern and Brussels.

BAK Economics' chief economist Claude Maurer warns that ditching bilateral agreements with Bern could lead to a significant decline in Switzerland's economic growth between 2028 and 2045, amounting to a staggering $867 billion loss.

Maurer warns that slowing growth may lead to increased inflation, fueled by rising wages and subsequent interest rate hikes.

SVP lawmaker Thomas Matter labeled the population cap concerns as baseless alarmism.

According to Matter, a mere 10% of immigrants possessed highly valued professional skills, while economic expansion slowed significantly following the surge in immigration.

He emphasized that while his stance is not anti-immigration, a balanced approach is necessary to ensure the influx of suitable individuals.

Switzerland's landmass remains unchanged since 1848, yet its population has grown exponentially, leading to a pressing issue of overcrowding in this relatively small country.

Swiss multinational corporations such as Roche, Nestle, ABB, UBS, and Novartis are among those voicing opposition to the proposed population cap.

Roche expressed strong opposition to the proposal, citing potential damage to existing partnerships with the European Union and further exacerbating a critical labor shortage in skilled professionals. Companies heavily rely on the availability of highly trained workers from the EU.

Switzerland's hotel industry faces a pressing concern as some establishments may struggle to remain operational due to potential population cap measures, leading to increased costs and difficulties for international travelers.

This proposal masquerades as harmless, yet its underlying implications are far-reaching and potentially devastating. The exchange rate remains steady at $1 to 0.7902 Swiss francs.

Swiss multinational corporations such as Roche, Nestle, ABB, UBS,and Novartis are among those voicing opposition to the proposed population cap.